RESILIENCE | RC-102 | Oncology | IC DM

PRAISE (Patient-Reported AutoImmunity Secondary to Cancer immunothErapy) is a real-life longitudinal observational study aiming to identify autoimmune manifestations in patients treated with immune checkpoint inhibitors, either as monotherapy or in combination...